Tenofovir
Generic Name: tenofovir
Manufactured by HETERO DRUGS LTD. Dosage form: TABLET. Route: ORAL. Active ingredients: LAMIVUDINE (300MG/300MG); TENOFOVIR. Application: NDA022459.
Overview
Manufactured by HETERO DRUGS LTD. Dosage form: TABLET. Route: ORAL. Active ingredients: LAMIVUDINE (300MG/300MG); TENOFOVIR. Application: NDA022459.
Dosage
Available as tablet for oral use.
Related Medications
Sodium Ferric Gluconate Complex In Sucrose
sodium ferric gluconate complex in sucrose
Parenteral Iron Replacement [EPC]
11 DESCRIPTION Sodium ferric gluconate complex in sucrose injection, an iron replacement product, is a stable macromolecular complex with an apparent molecular weight on gel chromatography of 289,000 – 440,000 daltons. The macromolecular complex is negatively charged at alkaline pH and is present in solution with sodium cations. The product has a deep red color indicative of ferric oxide linkages. The chemical name is D-Gluconic acid, iron (3+) sodium salt.
Glycerin, Hypromellose, Polypropylene Glycol 400
glycerin, hypromellose, polypropylene glycol 400
Non-Standardized Chemical Allergen [EPC]
Purpose Glycerin.............Lubricant Hypromellose.............Lubricant Polyethylene glycol 400.............Lubricant
Bevacizumab-bvzr
bevacizumab-bvzr
Vascular Endothelial Growth Factor Inhibitor [EPC]
11 DESCRIPTION Bevacizumab-bvzr is a vascular endothelial growth factor inhibitor. Bevacizumab-bvzr is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab-bvzr has an approximate molecular weight of 149 kDa. Bevacizumab-bvzr is produced in a mammalian cell (Chinese Hamster Ovary) expression system.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.